Search Legislation

Commission Delegated Regulation (EU) 2020/217Show full title

Commission Delegated Regulation (EU) 2020/217 of 4 October 2019 amending, for the purposes of its adaptation to technical and scientific progress, Regulation (EC) No 1272/2008 of the European Parliament and of the Council on classification, labelling and packaging of substances and mixtures and correcting that Regulation (Text with EEA relevance)

 Help about what version

What Version

 Help about advanced features

Advanced Features

 Help about UK-EU Regulation

Legislation originating from the EU

When the UK left the EU, legislation.gov.uk published EU legislation that had been published by the EU up to IP completion day (31 December 2020 11.00 p.m.). On legislation.gov.uk, these items of legislation are kept up-to-date with any amendments made by the UK since then.

Close

This item of legislation originated from the EU

Legislation.gov.uk publishes the UK version. EUR-Lex publishes the EU version. The EU Exit Web Archive holds a snapshot of EUR-Lex’s version from IP completion day (31 December 2020 11.00 p.m.).

Changes over time for: Commission Delegated Regulation (EU) 2020/217 (Annexes only)

 Help about opening options

Changes to legislation:

This version of this Regulation was derived from EUR-Lex on IP completion day (31 December 2020 11:00 p.m.). It has not been amended by the UK since then. Find out more about legislation originating from the EU as published on legislation.gov.uk. Help about Changes to Legislation

Close

Changes to Legislation

Revised legislation carried on this site may not be fully up to date. At the current time any known changes or effects made by subsequent legislation have been applied to the text of the legislation you are viewing by the editorial team. Please see ‘Frequently Asked Questions’ for details regarding the timescales for which new effects are identified and recorded on this site.

ANNEX IU.K.

Part 2 of Annex II to Regulation (EC) No 1272/2008 is amended as follows:

(1)

The introductory paragraph is amended as follows:

The statements set out in sections 2.1 to 2.10 and 2.12 shall be assigned to mixtures in accordance with Article 25(6).

(2)

Section 2.12 is added:

2.12. Mixtures containing titanium dioxide

The label on the packaging of liquid mixtures containing 1 % or more of titanium dioxide particles with aerodynamic diameter equal to or below 10 μm shall bear the following statement:

EUH211: ‘Warning! Hazardous respirable droplets may be formed when sprayed. Do not breathe spray or mist.’

The label on the packaging of solid mixtures containing 1 % or more of titanium dioxide shall bear the following statement:

EUH212: ‘Warning! Hazardous respirable dust may be formed when used. Do not breathe dust.’

In addition, the label on the packaging of liquid and solid mixtures not intended for the general public and not classified as hazardous which are labelled with EUH211 or EUH212, shall bear statement EUH210.

ANNEX IIU.K.

In Part 3 of Annex III to Regulation (EC) No 1272/2008, the following rows EUH 211 and EUH 212 are inserted:

EUH211Language
BGВнимание! При пулверизация могат да се образуват опасни респирабилни капки. Не вдишвайте пулверизираната струя или мъгла.
ES¡Atención! Al rociar pueden formarse gotas respirables peligrosas. No respirar el aerosol.
CSPozor! Při postřiku se mohou vytvářet nebezpečné respirabilní kapičky. Nevdechujte aerosoly nebo mlhu.
DAAdvarsel! Der kan danne sig farlige respirable dråber, når der sprayes. Undgå indånding af spray eller tåge.
DEAchtung! Beim Sprühen können gefährliche lungengängige Tröpfchen entstehen. Aerosol oder Nebel nicht einatmen.
ETHoiatus! Pihustamisel võivad tekkida ohtlikud sissehingatavad piisad. Pihustatud ainet või udu mitte sisse hingata.
ELΠροσοχή! Κατά τον ψεκασμό μπορούν να σχηματιστούν επικίνδυνα εισπνεύσιμα σταγονίδια. Μην αναπνέετε το εκνέφωμα ή τα σταγονίδια.
ENWarning! Hazardous respirable droplets may be formed when sprayed. Do not breathe spray or mist.
FRAttention! Des gouttelettes respirables dangereuses peuvent se former lors de la pulvérisation. Ne pas respirer les aérosols ni les brouillards.
GAAire! D’fhéadfaí braoiníní guaiseacha inanálaithe a chruthú nuair a spraeáiltear an táirge seo. Ná hanálaigh sprae ná ceo.
HRUpozorenje! Pri prskanju mogu nastati opasne respirabilne kapljice. Ne udisati aerosol ni maglicu.
ITAttenzione! In caso di vaporizzazione possono formarsi goccioline respirabili pericolose. Non respirare i vapori o le nebbie.
LVUzmanību! Izsmidzinot var veidoties bīstami ieelpojami pilieni. Ne smidzinājumu, ne miglu neieelpot.
LTAtsargiai! Purškiant gali susidaryti pavojingų įkvepiamų lašelių. Neįkvėpti rūko ar aerozolio.
HUFigyelem! Permetezés közben veszélyes, belélegezhető cseppek képződhetnek. A permetet vagy a ködöt nem szabad belélegezni.
MTTwissija! Jista’ jifforma qtar perikoluż li jinġibed man-nifs meta tisprejja minn dan. Tiġbidx l-isprej jew l-irxiex man-nifs.
NLLet op! Bij verneveling kunnen gevaarlijke inhaleerbare druppels worden gevormd. Spuitnevel niet inademen.
PLUwaga! W przypadku rozpylania mogą się tworzyć niebezpieczne respirabilne kropelki. Nie wdychać rozpylonej cieczy lub mgły.
PTAtenção! Podem formar-se gotículas inaláveis perigosas ao pulverizar. Não respirar a pulverização ou névoas.
ROAvertizare! Se pot forma picături respirabile periculoase la pulverizare. Nu respirați prin pulverizare sau ceață.
SKPozor! Pri rozprašovaní sa môžu vytvárať nebezpečné respirabilné kvapôčky. Nevdychujte aerosóly ani hmlu.
SLPozor! Pri razprševanju lahko nastanejo nevarne vdihljive kapljice. Ne vdihavajte razpršila ali meglic.
FIVaroitus! Vaarallisia keuhkorakkuloihin kulkeutuvia pisaroita saattaa muodostua suihkutuksen yhteydessä. Älä hengitä suihketta tai sumua.
SVVarning! Farliga respirabla droppar kan bildas vid sprejning. Inandas inte sprej eller dimma.
EUH212Language
BGВнимание! При употреба може да се образува опасен респирабилен прах. Не вдишвайте праха.
ES¡Atención! Al utilizarse, puede formarse polvo respirable peligroso. No respirar el polvo.
CSPozor! Při použití se může vytvářet nebezpečný respirabilní prach. Nevdechujte prach.
DAAdvarsel! Der kan danne sig farligt respirabelt støv ved anvendelsen. Undgå indånding af støv.
DEAchtung! Bei der Verwendung kann gefährlicher lungengängiger Staub entstehen. Staub nicht einatmen.
ETHoiatus! Kasutamisel võib tekkida ohtlik sissehingatav tolm. Tolmu mitte sisse hingata.
ELΠροσοχή! Κατά τη χρήση μπορεί να σχηματιστεί επικίνδυνη εισπνεύσιμη σκόνη. Μην αναπνέετε τη σκόνη.
ENWarning! Hazardous respirable dust may be formed when used. Do not breathe dust.
FRAttention! Une poussière respirable dangereuse peut se former lors de l’utilisation. Ne pas respirer cette poussière.
GAAire! D’fhéadfaí deannach guaiseach inanálaithe a chruthú nuair a úsáidtear an táirge seo. Ná hanálaigh deannach.
HRUpozorenje! Pri prskanju može nastati opasna respirabilna prašina. Ne udisati prašinu.
ITAttenzione! In caso di utilizzo possono formarsi polveri respirabili pericolose. Non respirare le polveri.
LVUzmanību! Izmantojot var veidoties bīstami ieelpojami putekļi. Putekļus neieelpot.
LTAtsargiai! Naudojant gali susidaryti pavojingų įkvepiamų dulkių. Neįkvėpti dulkių.
HUFigyelem! Használatkor veszélyes, belélegezhető por képződhet. A port nem szabad belélegezni.
MTTwissija! Meta jintuża dan, jista’ jifforma trab perikoluż li jinġibed man-nifs. Tiġbidx it-trab man-nifs.
NLLet op! Bij gebruik kunnen gevaarlijke inhaleerbare stofdeeltjes worden gevormd. Stof niet inademen.
PLUwaga! W przypadku stosowania może się tworzyć niebezpieczny pył respirabilny. Nie wdychać pyłu.
PTAtenção! Podem formar-se poeiras inaláveis perigosas ao pulverizar. Não respirar as poeiras.
ROAvertizare! Se poate forma pulbere respirabilă periculoasă în timpul utilizării. Nu inspirați pulberea.
SKPozor! Pri použití sa môže vytvárať nebezpečný respirabilný prach. Nevdychujte prach.
SLPozor! Pri uporabi lahko nastane nevaren vdihljiv prah. Prahu ne vdihavajte.
FIVaroitus! Vaarallista keuhkorakkuloihin kulkeutuvaa pölyä saattaa muodostua käytön yhteydessä. Älä hengitä pölyä.
SVVarning! Farligt respirabelt damm kan bildas vid användning. Inandas inte damm.

ANNEX IIIU.K.

Annex VI to Regulation (EC) No 1272/2008 is amended as follows:

(1)

Part 1 is amended as follows:

(a)

in point 1.1.3.1, the following notes V and W are added:

Note V:

If the substance is to be placed on the market as fibres (with diameter < 3 μm, length > 5 μm and aspect ratio ≥ 3:1) or particles of the substance fulfilling the WHO fibre criteria or as particles with modified surface chemistry, their hazardous properties must be evaluated in accordance with Title II of this Regulation, to assess whether a higher category (Carc. 1B or 1A) and/or additional routes of exposure (oral or dermal) should be applied.

Note W:

‘It has been observed that the carcinogenic hazard of this substance arises when respirable dust is inhaled in quantities leading to significant impairment of particle clearance mechanisms in the lung.

This note aims to describe the particular toxicity of the substance; it does not constitute a criterion for classification according to this Regulation.’;

(b)

in point 1.1.3.2, the following note 10 is added:

Note 10:

The classification as a carcinogen by inhalation applies only to mixtures in powder form containing 1 % or more of titanium dioxide which is in the form of or incorporated in particles with aerodynamic diameter ≤ 10 μm.;

(2)

in Part 3, Table 3 is amended as follows:

(a)

the rows with index numbers 604-083-00-X and 611-159-00-6 are deleted;

(b)

the rows corresponding to index numbers 015-189-00-5, 027-001-00-9, 028-018-00-4, 603-023-00-X, 605-005-00-7, 606-047-00-9, 607-232-00-7, 607-247-00-9, 608-039-00-0, 613-054-00-0, 616-018-00-2 and 648-055-00-5 are replaced by the following rows respectively:

Index No Chemical name EC No CAS No Classification Labelling Specific Conc. Limits, M-factors and ATEs Notes
Hazard Class and Category Code(s) Hazard statement Code(s) Pictogram, Signal Word Code(s) Hazard statement Code(s) Suppl. Hazard statement Code(s)
‘015-189-00-5phenyl bis(2,4,6-trimethylbenzoyl)-phosphine oxide423-340-5162881-26-7

Skin Sens. 1A

Aquatic Chronic 4

H317

H413

GHS07

Wng

H317

H413’

‘027-001-00-9cobalt231-158-07440-48-4

Carc. 1B

Muta. 2

Repr. 1B

Resp. Sens. 1

Skin Sens. 1

Aquatic Chronic 4

H350

H341

H360F

H334

H317

H413

GHS08

Dgr

H350

H341

H360F

H334

H317

H413’

‘028-018-00-4

nickel bis(sulfamidate);

nickel sulfamate

237-396-113770-89-3

Carc. 1A

Muta. 2

Repr. 1B

Acute Tox. 4

STOT RE 1

Resp. Sens. 1

Skin Sens. 1

Aquatic Acute 1

Aquatic Chronic 1

H350i

H341

H360D***

H302

H372**

H334

H317

H400

H410

GHS08

GHS07

GHS09

Dgr

H350i

H341

H360D***

H302

H372**

H334

H317

H410

oral: ATE = 853 mg/kg bw (anhydrate)

oral: ATE = 1098 mg/kg bw (tetrahydrate)

STOT RE 1;

H372: C ≥ 1 %

STOT RE 2;

H373: 0,1 % ≤ C < 1 %

Skin Sens. 1;

H317: C ≥ 0,01 %

M = 1’

‘603-023-00-X

ethylene oxide;

oxirane

200-849-975-21-8

Flam. Gas 1

Press. Gas

Carc. 1B

Muta. 1B

Repr. 1B

Acute Tox. 3

Acute Tox. 3

STOT SE 3

STOT SE 3

STOT RE 1

Skin Corr. 1

Eye Dam. 1

H220

H350

H340

H360Fd

H331

H301

H335

H336

H372 (nervous system)

H314

H318

GHS02

GHS08

GHS06

GHS05

Dgr

H220

H350

H340

H360Fd

H331

H301

H335

H336

H372 (nervous system)

H314

inhalation: ATE = 700ppm (gases)

oral: ATE = 100 mg/kg bw’

U
‘605-005-00-7

metaldehyde (ISO);

2,4,6,8-tetramethyl-1,3,5,7-tetraoxacyclooctane

203-600-2108-62-3

Flam. Sol. 2

Repr. 2

Acute Tox. 3

Aquatic Chronic 3

H228

H361f

H301

H412

GHS02

GHS08

GHS06

Dgr

H228

H361f

H301

H412

oral: ATE = 283 mg/kg bw’
‘606-047-00-92-benzyl-2-dimethylamino-4'-morpholinobutyrophenone404-360-3119313-12-1

Repr. 1B

Aquatic Acute 1

Aquatic Chronic 1

H360D

H400

H410

GHS08

GHS09

Dgr

H360D

H410’

‘607-232-00-7

pyridate (ISO);

O-(6-chloro-3-phenylpyridazin-4-yl) S-octyl thiocarbonate

259-686-755512-33-9

Acute Tox. 4

Skin Irrit. 2

Skin Sens. 1

Aquatic Acute 1

Aquatic Chronic 1

H302

H315

H317

H400

H410

GHS07

GHS09

Wng

H302

H315

H317

H410

oral: ATE = 500 mg/kg bw

M = 1

M = 10’

‘607-247-00-9dodecyl methacrylate205-570-6142-90-5STOT SE 3H335

GHS07

Wng

H335STOT SE 3; H335: C ≥ 10 %’
‘608-039-00-02-phenylhexanenitrile423-460-83508-98-3

Acute Tox. 4

Aquatic Chronic 2

H302

H411

GHS07

GHS09

Wng

H302

H411

oral:

ATE = 500 mg/kg bw’

‘613-054-00-0

thiabendazole (ISO);

2-(thiazol-4-yl)benzimidazole

205-725-8148-79-8Aquatic Acute 1 Aquatic Chronic 1

H400

H410

GHS09

Wng

H410

M = 1

M = 1’

‘616-018-00-2diethyltoluamide (ISO): N,N-diethyl-m-toluamide; [deet]205-149-7134-62-3

Acute Tox. 4

Skin Irrit. 2

Eye Irrit. 2

H302

H315

H319

GHS07

Wng

H302

H315

H319

oral:

ATE = 1892 mg/kg bw’

(c)

the following rows are inserted:

Index No Chemical Name EC No CAS No Classification Labelling Specific Conc. Limits, M-factors and ATEs Notes
Hazard Class and Category Code(s) Hazard statement Code(s) Pictogram, Signal Word Code(s) Hazard statement Code(s) Suppl. Hazard statement Code(s)
‘022-006-002

titanium dioxide;

[in powder form containing 1 % or more of particles with aerodynamic diameter ≤ 10 μm]

236-675-513463-67-7Carc. 2H351 (inhalation)

GHS08

Wng

H351 (inhalation)V, W, 10’
‘080-012-00-0methylmercuric chloride204-064-2115-09-3

Carc. 2

Repr. 1A

Lact.

Acute Tox. 2

Acute Tox. 2

Acute Tox. 2

STOT RE 1

Aquatic Acute 1

Aquatic Chronic 1

H351

H360Df

H362

H330

H310

H300

H372 (nervous system, kidneys)

H400

H410

GHS08

GHS06

GHS09

Dgr

H351

H360Df

H362

H330

H310

H300

H372 (nervous system, kidneys)

H410

inhalation: ATE = 0,05 mg/l (dusts or mists)

dermal: ATE = 50 mg/kg bw

oral: ATE = 5 mg/kg bw

1’
‘601-090-00-Xbenzo[rst]pentaphene205-877-5189-55-9

Carc. 1B

Muta. 2

H350

H341

GHS08

Dgr

H350

H341’

‘601-091-00-5

dibenzo[b,def]chrysene;

dibenzo[a,h]pyrene

205-878-0189-64-0

Carc. 1B

Muta. 2

H350

H341

GHS08

Dgr

H350

H341’

‘603-236-00-8ethanol, 2,2’-iminobis-, N-(C13-15-branched and linear alkyl) derivs.308-208-697925-95-6Repr. 1BH360D

GHS08

Dgr

H360D’
‘607-733-00-0

cyflumetofen (ISO);

2-methoxyethyl (RS)-2-(4-tert-butylphenyl)-2-cyano-3-oxo-3-(α,α,α-trifluoro-o-tolyl)propionate

400882-07-7

Carc. 2

Skin Sens. 1A

H351

H317

GHS08

GHS07

Wng

H351

H317’

‘607-734-00-6pentapotassium 2,2’,2’’,2’’’,2’’’’-(ethane-1,2-diylnitrilo)pentaacetate404-290-37216-95-7

Acute Tox. 4 STOT RE 2

Eye Irrit. 2

H332

H373 (inhalation)

H319

GHS08

GHS07

Dgr

H332

H373 (inhalation)

H319

inhalation:

ATE = 1,5 mg/l (dusts or mists)’

‘607-735-00-1N-carboxymethyliminobis(ethylenenitrilo)tetra(acetic acid)200-652-867-43-6

Acute Tox. 4 STOT RE 2

Eye Irrit. 2

H332

H373 (inhalation)

H319

GHS08

GHS07

Dgr

H332

H373 (inhalation)

H319

inhalation:

ATE = 1,5 mg/l (dusts or mists)’

‘607-736-00-7pentasodium (carboxylatomethyl)iminobis(ethylenenitrilo)tetraacetate205-391-3140-01-2

Acute Tox. 4

STOT RE 2

H332

H373 (inhalation)

GHS08

GHS07

Dgr

H332

H373 (inhalation)

inhalation:

ATE = 1,5 mg/l (dusts or mists)’

‘607-737-00-2diisohexyl phthalate276-090-271850-09-4Repr. 1BH360FD

GHS08

Dgr

H360FD’
‘608-069-00-4fludioxonil (ISO); 4-(2,2-difluoro-1,3-benzodioxol-4-yl)-1H-pyrrole-3-carbonitrile131341-86-1

Aquatic Acute 1

Aquatic Chronic 1

H400

H410

GHS09

Wng

H410

M = 1

M = 10’

‘613-329-00-5

halosulfuron-methyl (ISO);

methyl 3-chloro-5-{[(4,6-dimethoxypyrimidin-2-yl)carbamoyl]sulfamoyl}-1-methyl-1H-pyrazole-4-carboxylate

100784-20-1

Repr. 1B

Aquatic Acute 1

Aquatic Chronic 1

H360D

H400

H410

GHS08

GHS09

Dgr

H360D

H410

M = 1000

M = 1000’

613-330-00-02-methylimidazole211-765-7693-98-1Repr. 1BH360Df

GHS08

Dgr

H360Df
‘616-225-00-8(RS)-2-methoxy-N-methyl-2-[α-(2,5-xylyloxy)-o-tolyl]acetamide; mandestrobin173662-97-0Aquatic Acute 1 Aquatic Chronic 1

H400

H410

GHS09

Wng

H410

M = 1

M = 10’

‘616-226-00-3

carboxin (ISO);

2-methyl-N-phenyl-5,6-dihydro-1,4-oxathiine-3-carboxamide; 5,6-dihydro-2-methyl-1,4-oxathiine-3-carboxanilide

226-031-15234-68-4

STOT RE 2

Skin Sens. 1

Aquatic Acute 1

Aquatic Chronic 1

H373 (kidneys)

H317

H400

H410

GHS08

GHS07

GHS09

Wng

H373 (kidneys)

H317

H410

M = 1

M = 1’

‘616-227-00-9

metaflumizone (ISO); (EZ)-2’-[2-(4-cyanophenyl)-1-(α,α,α -trifluoro-m-tolyl)ethylidene]-[4-(trifluoromethoxy)phenyl]carbanilohydrazide [E-isomer ≥ 90 %, Z-isomer ≤ 10 % relative content]; [1]

(E)-2’-[2-(4-cyanophenyl)-1-(α,α,α -trifluoro-m-tolyl)ethylidene]-[4-(trifluoromethoxy)phenyl]carbanilohydrazide [2]

139968-49-3 [1]

852403-68-0 [2]

Repr. 2

Lact.

STOT RE 2

H361fd

H362

H373

GHS08

Wng

H361fd

H362

H373’

‘650-056-00-0dibutylbis(pentane-2,4-dionato-O,O’)tin245-152-022673-19-4

Repr. 1B

STOT RE 1

H360FD

H372 (immune system)

GHS08

Dgr

H360FD

H372 (immune system)’.

ANNEX IVU.K.

In Annex VI to Regulation (EC) No 1272/2008, in table 3, the row with Index No ‘648-055-00-5’ is replaced by the following:

Index No Chemical name EC No Cas No Classification Labelling Specific Conc. Limits, M-factors and ATEs Notes
Hazard Class and Category Code(s) Hazard statement Code(s) Pictogram, Signal Word Code(s) Hazard statement Code(s) Suppl. Hazard statement Code(s)
‘648-055-00-5pitch, coal tar, high-temp.; [The residue from the distillation of high temperature coal tar. A black solid with an approximate softening point from 30 °C to 180 °C (86 °F to 356 °F). Composed primarily of a complex mixture of three or more membered condensed ring aromatic hydrocarbons.]266-028-265996-93-2

Carc. 1A

Muta. 1B

Repr. 1B

H350

H340

H360FD

GHS08

Dgr

H350

H340

H360FD’.

Back to top

Options/Help

Print Options

Close

Legislation is available in different versions:

Latest Available (revised):The latest available updated version of the legislation incorporating changes made by subsequent legislation and applied by our editorial team. Changes we have not yet applied to the text, can be found in the ‘Changes to Legislation’ area.

Original (As adopted by EU): The original version of the legislation as it stood when it was first adopted in the EU. No changes have been applied to the text.

Close

See additional information alongside the content

Geographical Extent: Indicates the geographical area that this provision applies to. For further information see ‘Frequently Asked Questions’.

Show Timeline of Changes: See how this legislation has or could change over time. Turning this feature on will show extra navigation options to go to these specific points in time. Return to the latest available version by using the controls above in the What Version box.

Close

Opening Options

Different options to open legislation in order to view more content on screen at once

Close

More Resources

Access essential accompanying documents and information for this legislation item from this tab. Dependent on the legislation item being viewed this may include:

  • the original print PDF of the as adopted version that was used for the EU Official Journal
  • lists of changes made by and/or affecting this legislation item
  • all formats of all associated documents
  • correction slips
  • links to related legislation and further information resources
Close

Timeline of Changes

This timeline shows the different versions taken from EUR-Lex before exit day and during the implementation period as well as any subsequent versions created after the implementation period as a result of changes made by UK legislation.

The dates for the EU versions are taken from the document dates on EUR-Lex and may not always coincide with when the changes came into force for the document.

For any versions created after the implementation period as a result of changes made by UK legislation the date will coincide with the earliest date on which the change (e.g an insertion, a repeal or a substitution) that was applied came into force. For further information see our guide to revised legislation on Understanding Legislation.

Close

More Resources

Use this menu to access essential accompanying documents and information for this legislation item. Dependent on the legislation item being viewed this may include:

  • the original print PDF of the as adopted version that was used for the print copy
  • correction slips

Click 'View More' or select 'More Resources' tab for additional information including:

  • lists of changes made by and/or affecting this legislation item
  • confers power and blanket amendment details
  • all formats of all associated documents
  • links to related legislation and further information resources